Cargando…
Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
BACKGROUND: Expression of SRY [sex-determining region Y]-box11 (SOX11) is specific to mantle cell lymphoma (MCL) and contributes, in conjunction with immunoglobulin variable heavy chain gene mutation status, to the identification of two forms of this disease. METHODS: The aim of this report was firs...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819690/ https://www.ncbi.nlm.nih.gov/pubmed/29484276 http://dx.doi.org/10.1186/s40164-018-0097-6 |
_version_ | 1783301252856152064 |
---|---|
author | Magne, Julien Jenvrin, Alizée Chauchet, Adrien Casasnovas, Olivier Donzel, Anne Jego, Laurence Aral, Bernard Guy, Julien Nadal, Nathalie Vernerey, Dewi Callier, Patrick Garnache-Ottou, Francine Ferrand, Christophe |
author_facet | Magne, Julien Jenvrin, Alizée Chauchet, Adrien Casasnovas, Olivier Donzel, Anne Jego, Laurence Aral, Bernard Guy, Julien Nadal, Nathalie Vernerey, Dewi Callier, Patrick Garnache-Ottou, Francine Ferrand, Christophe |
author_sort | Magne, Julien |
collection | PubMed |
description | BACKGROUND: Expression of SRY [sex-determining region Y]-box11 (SOX11) is specific to mantle cell lymphoma (MCL) and contributes, in conjunction with immunoglobulin variable heavy chain gene mutation status, to the identification of two forms of this disease. METHODS: The aim of this report was firstly, to design an easy and suitable RT-qPCR method to quantify SOX11 mRNA expression in mantle cell lymphoma and other B cell malignancies with the proper reference gene; secondly, to define the best threshold of relative quantity of SOX11 mRNA in order to reach the best compromise between sensitivity and specificity. RESULTS: For best discrimination of MCL and non-MCL groups we determined an area under the curve (AUC) of 0.9750 and a threshold of 1.76 with 100% sensitivity and 88% specificity. AUC and threshold values of respectively 0.91/1.346 [87% sensitivity, 80% specificity] and 0.9525/1.7120 [100% sensitivity, 88% specificity] for GAPDH and RPLP0 respectively denote that the RPLP0 reference gene alone is sufficient for PCR housekeeping gene. CONCLUSION: This work describes an RT-qPCR assay for SOX11 expression in order to better characterize MCL at diagnosis. Further studies on larger cohorts are needed to evaluate this molecular tool, especially for the follow-up of minimal residual disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40164-018-0097-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5819690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58196902018-02-26 Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies Magne, Julien Jenvrin, Alizée Chauchet, Adrien Casasnovas, Olivier Donzel, Anne Jego, Laurence Aral, Bernard Guy, Julien Nadal, Nathalie Vernerey, Dewi Callier, Patrick Garnache-Ottou, Francine Ferrand, Christophe Exp Hematol Oncol Rapid Communication BACKGROUND: Expression of SRY [sex-determining region Y]-box11 (SOX11) is specific to mantle cell lymphoma (MCL) and contributes, in conjunction with immunoglobulin variable heavy chain gene mutation status, to the identification of two forms of this disease. METHODS: The aim of this report was firstly, to design an easy and suitable RT-qPCR method to quantify SOX11 mRNA expression in mantle cell lymphoma and other B cell malignancies with the proper reference gene; secondly, to define the best threshold of relative quantity of SOX11 mRNA in order to reach the best compromise between sensitivity and specificity. RESULTS: For best discrimination of MCL and non-MCL groups we determined an area under the curve (AUC) of 0.9750 and a threshold of 1.76 with 100% sensitivity and 88% specificity. AUC and threshold values of respectively 0.91/1.346 [87% sensitivity, 80% specificity] and 0.9525/1.7120 [100% sensitivity, 88% specificity] for GAPDH and RPLP0 respectively denote that the RPLP0 reference gene alone is sufficient for PCR housekeeping gene. CONCLUSION: This work describes an RT-qPCR assay for SOX11 expression in order to better characterize MCL at diagnosis. Further studies on larger cohorts are needed to evaluate this molecular tool, especially for the follow-up of minimal residual disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40164-018-0097-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-20 /pmc/articles/PMC5819690/ /pubmed/29484276 http://dx.doi.org/10.1186/s40164-018-0097-6 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Rapid Communication Magne, Julien Jenvrin, Alizée Chauchet, Adrien Casasnovas, Olivier Donzel, Anne Jego, Laurence Aral, Bernard Guy, Julien Nadal, Nathalie Vernerey, Dewi Callier, Patrick Garnache-Ottou, Francine Ferrand, Christophe Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies |
title | Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies |
title_full | Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies |
title_fullStr | Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies |
title_full_unstemmed | Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies |
title_short | Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies |
title_sort | potential added value of a rt-qpcr method of sox 11 expression, in the context of a multidisciplinary diagnostic assessment of b cell malignancies |
topic | Rapid Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819690/ https://www.ncbi.nlm.nih.gov/pubmed/29484276 http://dx.doi.org/10.1186/s40164-018-0097-6 |
work_keys_str_mv | AT magnejulien potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT jenvrinalizee potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT chauchetadrien potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT casasnovasolivier potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT donzelanne potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT jegolaurence potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT aralbernard potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT guyjulien potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT nadalnathalie potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT vernereydewi potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT callierpatrick potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT garnacheottoufrancine potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies AT ferrandchristophe potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies |